Shanghai Fosun Pharmaceutical (Group) Co (HK:2196) has released an update.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. has successfully convened its 2024 first extraordinary general meeting, where shareholders voted on key resolutions and witnessed the election of a new non-executive director. The meeting saw a significant turnout with over 40% of shares with voting rights represented. Compliance with legal requirements and the presence of scrutineers ensured the integrity of the voting process.
For further insights into HK:2196 stock, check out TipRanks’ Stock Analysis page.